Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (101-110 of 263) with videos related to

Pageof 27
Sort By:
Frontiers in Immunology|November 3, 2018
Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against <i>Leishmania donovani</i>Malcolm S Duthie, Neal Van Hoeven, Zachary MacMillen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2014
Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosisMark T Orr, Gregory C Ireton, Elyse A Beebe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 PolarizationSimon D van Haren, David J Dowling, Willemina Foppen, et al.
NPJ Vaccines|April 23, 2022
An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21Hyo Jung Nam, Sung Jun Hong, Ara Lee, et al.
The American Journal of Tropical Medicine and Hygiene|November 28, 2002
The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infectionRegina F S Braz, Eliana T Nascimento, Daniella R A Martins, et al.
Plos One|September 29, 2017
Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatmentFaria Hossain, Prakash Ghosh, Md Anik Ashfaq Khan, et al.
Cytokine|April 16, 2016
In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvantSimon D van Haren, Lakshmi Ganapathi, Ilana Bergelson, et al.
Infection and Immunity|July 16, 2002
Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasisRhea N Coler, Yasir A W Skeiky, Karen Bernards, et al.
Science Translational Medicine|July 29, 2011
Targeting TLRs expands the antibody repertoire in response to a malaria vaccineSteven R Wiley, Vanitha S Raman, Anthony Desbien, et al.
The Journal of Infectious Diseases|February 1, 2015
Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of TuberculosisMark T Orr, Hillarie Plessner Windish, Elyse A Beebe, et al.
Pageof 27

Showing results (101-110 of 263) with videos related to

Sort By:
Pageof 27
Frontiers in Immunology|November 3, 2018
Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against <i>Leishmania donovani</i>Malcolm S Duthie, Neal Van Hoeven, Zachary MacMillen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2014
Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosisMark T Orr, Gregory C Ireton, Elyse A Beebe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 PolarizationSimon D van Haren, David J Dowling, Willemina Foppen, et al.
NPJ Vaccines|April 23, 2022
An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21Hyo Jung Nam, Sung Jun Hong, Ara Lee, et al.
The American Journal of Tropical Medicine and Hygiene|November 28, 2002
The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infectionRegina F S Braz, Eliana T Nascimento, Daniella R A Martins, et al.
Plos One|September 29, 2017
Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatmentFaria Hossain, Prakash Ghosh, Md Anik Ashfaq Khan, et al.
Cytokine|April 16, 2016
In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvantSimon D van Haren, Lakshmi Ganapathi, Ilana Bergelson, et al.
Infection and Immunity|July 16, 2002
Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasisRhea N Coler, Yasir A W Skeiky, Karen Bernards, et al.
Science Translational Medicine|July 29, 2011
Targeting TLRs expands the antibody repertoire in response to a malaria vaccineSteven R Wiley, Vanitha S Raman, Anthony Desbien, et al.
The Journal of Infectious Diseases|February 1, 2015
Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of TuberculosisMark T Orr, Hillarie Plessner Windish, Elyse A Beebe, et al.
Pageof 27